OptiBiotix Health PLC (LON:OPTI)‘s stock had its “corporate” rating restated by equities researchers at FinnCap in a report released on Wednesday.
Shares of OptiBiotix Health PLC (LON:OPTI) opened at 69.50 on Wednesday. OptiBiotix Health PLC has a 52-week low of GBX 59.00 and a 52-week high of GBX 90.00. The firm’s market capitalization is GBX 54.31 million. The stock has a 50 day moving average price of GBX 67.17 and a 200-day moving average price of GBX 70.69.
COPYRIGHT VIOLATION WARNING: This article was originally reported by Stock Observer and is the sole property of of Stock Observer. If you are reading this article on another site, it was illegally stolen and reposted in violation of US and international copyright law. The original version of this article can be read at https://www.thestockobserver.com/2017/09/13/optibiotix-health-plc-opti-given-corporate-rating-at-finncap.html.
OptiBiotix Health PLC Company Profile
Optibiotix Health Plc is a life sciences company developing a range of products to modify the human microbiome. The Company’s principal activity is research and development into microbiome modulators. It operates in UK segment. The Company has a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression.
Receive News & Ratings for OptiBiotix Health PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health PLC and related companies with MarketBeat.com's FREE daily email newsletter.